{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:30:55Z","timestamp":1761597055579,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.jinf.2007.10.005","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T03:28:42Z","timestamp":1196479722000},"page":"40-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Antiretroviral therapy in AIDS patients with CMV disease: Impact on the survival and long-term treatment outcome"],"prefix":"10.1016","volume":"56","author":[{"given":"Somnuek","family":"Sungkanuparph","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taywin","family":"Chakriyanuyok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bodin","family":"Butthum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2007.10.005_bib1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ophtha.2004.10.049","article-title":"Studies of ocular complications of AIDS Research Group: risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy","volume":"112","author":"Jabs","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jinf.2007.10.005_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archopht.121.1.99","article-title":"Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy","volume":"121","author":"Holbrook","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jinf.2007.10.005_bib3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00042560-199511000-00004","article-title":"Evidence of active cytomegalovirus infection in clinically stable HIV-infected individuals with CD4+ lymphocyte counts below 100\/microliters of blood: features and relation to risk of subsequent CMV retinitis","volume":"10","author":"MacGregor","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.jinf.2007.10.005_bib4","first-page":"357","article-title":"Autopsy pathology in the acquired immune deficiency syndrome","volume":"112","author":"Reichert","year":"1983","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jinf.2007.10.005_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(03)13802-0","article-title":"Decline in the AIDS and death rates in the\u00a0EuroSIDA study: an observational study","volume":"362","author":"Mocroft","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2007.10.005_bib6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0140-6736(05)67022-5","article-title":"Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study","volume":"366","author":"Sterne","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2007.10.005_bib7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1086\/314943","article-title":"Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy","volume":"180","author":"O'Sullivan","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2007.10.005_bib8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s15010-005-5050-z","article-title":"Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy","volume":"33","author":"Salzberger","year":"2005","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2007.10.005_bib9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/jac\/dkh396","article-title":"Cytomegalovirus infection in the era of HAART: fewer reactivations and more immunity","volume":"54","author":"Springer","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2007.10.005_bib10","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/bjo.83.6.652","article-title":"Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study","volume":"83","author":"Mitchell","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jinf.2007.10.005_bib11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1468-1293.2004.00245.x","article-title":"Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy","volume":"5","author":"Keane","year":"2004","journal-title":"HIV Med"},{"key":"10.1016\/j.jinf.2007.10.005_bib12","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1086\/379077","article-title":"Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome","volume":"37","author":"Kempen","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2007.10.005_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00002030-200301030-00010","article-title":"Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia","volume":"17","author":"Morris","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2007.10.005_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.qai.0000230521.86964.86","article-title":"Survival rate and risk factors of mortality among HIV\/tuberculosis-coinfected patients with and without antiretroviral therapy","volume":"43","author":"Manosuthi","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2007.10.005_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/157016207780636551","article-title":"Impact of antiretroviral therapy on the relapse of cryptococcosis and survival of HIV-infected patients with cryptococcal infection","volume":"5","author":"Jongwutiwes","year":"2007","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.jinf.2007.10.005_bib16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1089\/apc.2005.19.626","article-title":"Cerebral toxoplasmosis in HIV-positive patients in Brazil: clinical features and predictors of treatment response in the HAART era","volume":"19","author":"Vidal","year":"2005","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.jinf.2007.10.005_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/135965350601100104","article-title":"Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity","volume":"11","author":"Jansen","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jinf.2007.10.005_bib18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00006982-200206000-00003","article-title":"Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors","volume":"22","author":"Lin","year":"2002","journal-title":"Retina"},{"key":"10.1016\/j.jinf.2007.10.005_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-137-4-200208200-00008","article-title":"Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy","volume":"137","author":"Kirk","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2007.10.005_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0896-1549(02)00048-2","article-title":"Cytomegalovirus retinitis in the era of combined highly active antiretroviral therapy","volume":"15","author":"See","year":"2002","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.jinf.2007.10.005_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1310\/4J65-4YX1-4ET6-E5KR","article-title":"The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy","volume":"6","author":"Wohl","year":"2005","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.jinf.2007.10.005_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1310\/9M23-QN0X-W6N8-80JD","article-title":"Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis","volume":"7","author":"Walmsley","year":"2006","journal-title":"HIV Clin Trials"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445307007888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445307007888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:32:15Z","timestamp":1758987135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445307007888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0163445307007888"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2007.10.005","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiretroviral therapy in AIDS patients with CMV disease: Impact on the survival and long-term treatment outcome","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2007.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}